Phreesia Class Action Lawsuit Filed
Analysis based on 8 articles · First reported May 18, 2026 · Last updated Jun 03, 2026
The class action lawsuit against Phreesia and its lowered revenue outlook have negatively impacted investor confidence in Phreesia, causing its stock price to fall by approximately 27%. This event highlights the risks associated with companies' financial guidance and the potential for legal repercussions when disclosures are deemed misleading.
Robbins LLP has filed a class action lawsuit against Phreesia, Inc. on behalf of investors who purchased common stock between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia misled investors regarding the sustainability of growth in its Network Solutions business and its fiscal year 2027 revenue outlook. Specifically, the complaint states that Phreesia failed to disclose weakening pharmaceutical marketing commitments, reduced visibility into future spending from manufacturers, lower spending commitments from Network Solutions clients for the second half of fiscal year 2027, and increased variability in revenue forecasting. On March 30, 2026, Phreesia announced a lowered fiscal year 2027 revenue outlook, citing 'shorter visibility into spending commitments' and 'brand-specific dynamics including the impact of regulatory policies.' This news led to a 27% drop in Phreesia's stock price.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard